New User? Sign Up | Sign In

Insider Trading - NeuBase Therapeutics Inc. (NBSE)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
NBSE Insider Trading Transactions for NeuBase Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-01-19
Purchase
2016-01-20
10:33 am
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
6,250 $3.6169 $22,606 865,754
(Indirect
Direct)
View
2016-02-22
Purchase
2016-02-23
1:25 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
6,250 $3.109 $19,431 872,004
(Indirect
Direct)
View
2016-03-07
Purchase
2016-03-09
1:17 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
6,250 $3.627 $22,669 878,254
(Indirect
Direct)
View
2016-04-11
Purchase
2016-04-12
1:02 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
6,250 $3.35 $20,937 884,504
(Indirect
Direct)
View
2016-05-23
Purchase
2016-05-24
12:39 pm
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
2,500 $3.1704 $7,926 138,699
(Direct)
View
2016-05-23
Purchase
2016-05-25
1:25 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
28,068 $3.1487 $88,377 912,572
(Indirect
Direct)
View
2016-05-25
Purchase
2016-05-26
12:08 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
3,682 $3.1088 $11,447 916,254
(Indirect
Direct)
View
2016-06-20
Purchase
2016-06-21
12:41 pm
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
2,468 $2.8353 $6,997 141,167
(Direct)
View
2016-06-20
Purchase
2016-06-21
12:48 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
8,786 $2.8454 $25,000 925,040
(Indirect
Direct)
View
2017-04-10
Purchase
2017-04-13
11:11 am
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
142,858 $0.7 $100,001 1,649,605
(Indirect
Direct)
View
2017-04-10
Purchase
2017-04-13
12:59 pm
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
71,429 $0.7 $50,000 212,596
(Direct)
View
2017-04-10
Purchase
2017-04-13
2:45 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
142,858 $0.7 $100,001 1,067,898
(Indirect
Direct)
View
2017-04-10
Purchase(A)
2017-12-06
3:41 pm
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
171,429 $0.7 $120,000 1,678,177
(Indirect
Direct)
View
2020-04-30
Purchase
2020-05-04
09:56 am
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
10,833 $6 $64,998 36,080
(Indirect
Direct)
View
2020-04-30
Purchase
2020-05-04
12:28 pm
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
1,000 $6 $6,000 11,630
(Direct)
View
2020-04-30
Purchase
2020-05-04
2:18 pm
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
10,000 $6 $60,000 10,000
(Direct)
View
2020-04-30
Purchase
2020-05-04
3:25 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
10,000 $6 $60,000 10,000
(Indirect
Direct)
View
2020-05-21
Purchase
2020-05-26
4:39 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,250 $8.0888 $10,111 11,250
(Indirect
Direct)
View
2020-06-09
Purchase
2020-06-10
11:50 am
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,275 $7.7339 $9,861 12,525
(Indirect
Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-01-07
Option Award
2016-01-11
7:11 pm
N/A
2021-01-06
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
60,000 $5.14 60,000
(Direct)
View
2016-01-22
Option Award
2016-01-26
09:49 am
N/A
2021-01-21
Ohr Pharmaceutical Inc OHRP GREENSTEIN IRA A
Director
80,000 $3.62 80,000
(Direct)
View
2016-07-18
Other
2016-08-02
12:15 pm
N/A
N/A
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
497,859 $0 1,195,724
(Indirect)
View
2017-04-10
Purchase
2017-04-13
11:11 am
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
100,001 $1 1,649,605
(Direct)
View
2017-04-10
Purchase
2017-04-13
12:59 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
50,001 $1 212,596
(Direct)
View
2017-04-10
Purchase
2017-04-13
2:45 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
100,001 $1 1,067,898
(Direct)
View
2017-05-12
Option Award
2017-05-16
5:07 pm
N/A
2022-05-11
Ohr Pharmaceutical Inc OHRP Ferguson Michael
Director
750,000 $0.65 750,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:00 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
245,000 $0.67 245,000
(Direct)
View
2017-05-12
Option Award
2017-10-18
6:00 pm
N/A
2022-05-11
Ohr Pharmaceutical Inc OHRP Ferguson Michael
Director
500,000 $0.65 500,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Almenoff June Sherie
Director
170,000 $0.67 170,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
390,000 $0.67 390,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Riedhammer Thomas M
Director
170,000 $0.67 170,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:02 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
350,000 $0.67 350,000
(Direct)
View
2017-04-10
Purchase
2017-12-06
3:41 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
120,001 $1 1,678,177
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:32 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
772,923 $5.39 0
(Direct)
View
2019-07-12
Other
2019-07-16
8:32 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
3,000 $10.14 0
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:33 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
227,330 $5.39 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:34 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE Miralles Gines Diego
Director
227,330 $5.39 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
25,247 $0 227,330
(Indirect)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
227,330 $5.39 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
2,547,639 $0 3,311,930
(Indirect)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
2019-07-12
2028-12-31
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
3,311,930 $0.001 3,311,930
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:36 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
227,330 $5.39 227,330
(Direct)
View
2020-07-27
Option Award
2020-07-28
4:22 pm
N/A
2030-07-27
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
175,000 $7.46 175,000
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:19 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
14,634 $8.8 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
14,634 $8.8 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE Miralles Gines Diego
Director
14,634 $8.8 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
14,634 $8.8 14,634
(Direct)
View
Goto page 0, 1, Next